MedPath

广东安诺药业股份有限公司

Ownership
-
Established
2010-09-15
Employees
-
Market Cap
-
Website
http://www.annol.cn

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

31

NMPA:31

Drug Approvals

小青龙颗粒

Approval Number
国药准字Z20053275
Approval Date
Feb 20, 2020
NMPA

Diclofenac Potassium Tablets

Product Name
双氯芬酸钾片
Approval Number
国药准字H20020034
Approval Date
Jan 17, 2020
NMPA

Vitamin B2 Tablets

Product Name
维生素B2片
Approval Number
国药准字H44020881
Approval Date
Jan 17, 2020
NMPA

Norfloxacin Capsules

Product Name
诺氟沙星胶囊
Approval Number
国药准字H44020880
Approval Date
Jan 17, 2020
NMPA

Naproxen Capsules

Product Name
萘普生胶囊
Approval Number
国药准字H44020884
Approval Date
Jan 17, 2020
NMPA

Aciclovir Tablets

Product Name
阿昔洛韦片
Approval Number
国药准字H20054502
Approval Date
Jan 17, 2020
NMPA

Captopril Tablets

Product Name
卡托普利片
Approval Number
国药准字H44020878
Approval Date
Jan 17, 2020
NMPA

Ibuprofen Tablets

Product Name
布洛芬片
Approval Number
国药准字H44020874
Approval Date
Jan 17, 2020
NMPA

Azithromycin Dispersible Tablets

Product Name
阿奇霉素分散片
Approval Number
国药准字H20056665
Approval Date
Jan 16, 2020
NMPA

Compound Sulfamethoxazole Tablets

Product Name
复方磺胺甲噁唑片
Approval Number
国药准字H44021630
Approval Date
Jan 16, 2020
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.